Exclusive special offer and discount title banner vector image

EUROPE BOTULINUM TOXIN MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Europe Botulinum Toxin Market by Type (Type A Botulinum Toxin, Type B Botulinum Toxin) Market by User Demographic (Women, Men) Market by Application (Medical (Chronic Migraine, Muscle Spasm, Overactive Bladder, Hyperhidrosis, Other Medical Applications), Aesthetic (Crow’s Feet, Forehead Lines, Frown Lines/glabellar, Square Jaw/masseter, Other Aesthetic Applications)) Market by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users) by Geography


MARKET OVERVIEW

The Europe botulinum toxin market is anticipated to be valued at $4769.67 million by 2032, and is expected to surge with a 10.00% CAGR during the forecast period, 2023-2032.

Botulinum toxin procedures, including nonsurgical procedures, are gaining traction in various European countries due to rising consumer demand and an uncomplicated approval process by the European Medicines Agency for selling across the region. The European market is expected to grow significantly during the forecast period, driven by the presence of skilled professionals and an increase in the geriatric population. The rising demand for advanced treatment technologies in Europe is a key factor to drive market growth.

To Know More About This Report, Request a Free Sample Copy

The Europe botulinum toxin market growth analysis entails the evaluation of Spain, France, Italy, Poland, Nordic Countries, Germany, the United Kingdom, and Rest of Europe. The United Kingdom boasts a well-established healthcare system that is helping improve the health of its citizens. The country has made significant progress in healthcare development, providing complete public services free at the point of utilization, resulting in lower healthcare expenditure for individuals. In response to this growing trend, leading players in the botulinum toxin market focus on ongoing innovation and upgrading their product portfolio for better aesthetics and enhanced patient therapeutic outcomes.

Cosmetic surgery has seen a surge in demand in the United Kingdom as people seek to improve their physical appearance. With their vast experience in this field and the use of the latest technologies, German specialists have provided significant results, fueling the demand for cosmetic surgeries across the country. Modern techniques and methods of cosmetic surgery allow for high accuracy and help patients change their appearance while maintaining a natural look without risking their health.

Germany is expected to witness significant growth in botulinum toxin procedures, driven by increasing public awareness, an aging population, and a growing inclination toward cosmetic appearances. According to the International Society of Aesthetic Plastic Surgery (ISAPS) 2018 Statistics, non-surgical cosmetic procedures in Germany increased from about 536,150 in 2018 to 605,942 total non-surgical procedures in 2021.

The Europe botulinum toxin market segmentation assessment includes end-user, type, application, and user demographic. Market by type includes type A botulinum toxin and type B botulinum toxin.

Botulinum toxin type B, an alternative neurotoxin derived from Clostridium botulinum, is widely accepted for medical treatments. Type A and type B differ in their mechanism of action. Type A and type B attach to the receptor sites on motor neuron terminals, inhibiting acetylcholine release. 

Studies have evaluated the safety and efficacy of botulinum toxin type B in treating Hidradenitis Suppurativa and have found that it can improve the overall symptoms of the disease. Further research conducted at Boston’s Children’s Hospital has shown that introducing key amino acids through genetic engineering on the lipid-binding loop in botulinum toxin type B can make it more effective, longer-lasting, and exhibit fewer side effects. In August 2019, Myobloc (rimabotulinumtoxinB) received US FDA approval for treating chronic sialorrhea in adults, which is expected to contribute to the market’s growth. These developments highlight the potential for botulinum toxin type B in medical treatments and are expected to drive market growth in the coming years.

Leading companies operating in the Europe botulinum toxin market include Ipsen, Merz Pharma, etc.

Ipsen is a global specialty biopharmaceutical company that focuses on developing and commercializing novel medicines for cancer, neurological diseases, and rare diseases, including specialty pharmaceutical products. In addition, the company offers products to treat various conditions, such as gastrointestinal disorders, neurodegenerative pathologies, and rheumatic diseases. 

Ipsen distributes its drugs through a network of distributors and directly to hospitals in select countries. The company operates research and development facilities in Paris-Saclay, France; Oxford, the United Kingdom; and Cambridge, the United States, with headquarters in Paris, France.

One of Ipsen’s pharmaceutical products is Dysport (abobotulinumtoxin A), an acetylcholine release inhibitor and neuromuscular blocking agent. The medication is widely used in the cosmetic industry and has been approved for various medical indications, such as the treatment of muscle spasms and cervical dystonia.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Type, User Demographic, Application, and End-User
Countries AnalyzedUnited Kingdom, Germany, France, Italy, Spain, Nordic Countries, Poland, and Rest of Europe
Companies Analyzed

AbbVie Inc, Candela Medical, Daewoong Pharmaceutical Co Ltd, Evolus Inc, Galderma, Hugel Inc, Ipsen, Lanzhou Institute of Biological Products Co Ltd, Medytox, Merz Pharma, Revance Therapeutics Inc, US WorldMeds LLC

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    5. MAJOR MARKET FINDINGS
      1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
      2. GROWING AWARENESS ABOUT ‘NOTOX’
      3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
      2. RISING GERIATRIC POPULATION
      3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES 
    2. KEY RESTRAINTS
      1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR GERMANY
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY TYPE
    1. TYPE A BOTULINUM TOXIN
    2. TYPE B BOTULINUM TOXIN
  6. MARKET BY USER DEMOGRAPHIC
    1. WOMEN
    2. MEN
  7. MARKET BY APPLICATION
    1. MEDICAL
      1. CHRONIC MIGRAINE
      2. MUSCLE SPASM
      3. OVERACTIVE BLADDER
      4. HYPERHIDROSIS
      5. OTHER MEDICAL APPLICATIONS
    2. AESTHETIC
      1. CROW’S FEET
      2. FOREHEAD LINES
      3. FROWN LINES/GLABELLAR
      4. SQUARE JAW/MASSETER
      5. OTHER AESTHETIC APPLICATIONS
  8. MARKET BY END-USER
    1. SPECIALTY AND DERMATOLOGY CLINICS
    2. HOSPITALS AND CLINICS
    3. OTHER END-USERS
  9. GEOGRAPHICAL ANALYSIS
    1. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
      3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
      4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        6. NORDIC COUNTRIES
          1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  10. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES
      1. ABBVIE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. CANDELA MEDICAL
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. DAEWOONG PHARMACEUTICAL CO LTD
        1. COMPANY PROFILE
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. EVOLUS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. GALDERMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. HUGEL INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. IPSEN
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. MEDYTOX INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10. MERZ PHARMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. REVANCE THERAPEUTICS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      12. US WORLDMEDS LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST

LIST OF TABLES

TABLE 1: EUROPE MARKET SNAPSHOT – BOTULINUM TOXIN

TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES

TABLE 3: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 4: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 5: EUROPE BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 6: EUROPE BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 7: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 8: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 9: EUROPE BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 10: EUROPE BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 11: EUROPE BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 12: EUROPE BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 13: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 14: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 15: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 16: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 17: EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 18: KEY PLAYERS OPERATING IN EUROPE BOTULINUM TOXIN MARKET

TABLE 19: LIST OF ACQUISITIONS

TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 21: LIST OF PARTNERSHIPS 

TABLE 22: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR GERMANY

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022

FIGURE 7: EUROPE BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)

FIGURE 8: EUROPE BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)

FIGURE 9: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022

FIGURE 10: EUROPE BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2032 (IN $ MILLION)

FIGURE 11: EUROPE BOTULINUM TOXIN MARKET, BY MEN, 2023-2032 (IN $ MILLION)

FIGURE 12: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 13: EUROPE BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2032 (IN $ MILLION)

FIGURE 14: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022

FIGURE 15: EUROPE BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2032 (IN $ MILLION)

FIGURE 16: EUROPE BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2032 (IN $ MILLION)

FIGURE 17: EUROPE BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2032 (IN $ MILLION)

FIGURE 18: EUROPE BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2032 (IN $ MILLION)

FIGURE 19: EUROPE BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 20: EUROPE BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2032 (IN $ MILLION)

FIGURE 21: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022

FIGURE 22: EUROPE BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2032 (IN $ MILLION)

FIGURE 23: EUROPE BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2032 (IN $ MILLION)

FIGURE 24: EUROPE BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2032 (IN $ MILLION)

FIGURE 25: EUROPE BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2032 (IN $ MILLION)

FIGURE 26: EUROPE BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 27: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 28: EUROPE BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 29: EUROPE BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 30: EUROPE BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)

FIGURE 31: EUROPE BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 32: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 33: GERMANY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 34: FRANCE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 35: ITALY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 36: SPAIN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 37: NORDIC COUNTRIES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 38: POLAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 39: REST OF EUROPE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FAQ’s